Literature DB >> 21442235

Association analyses between the genetic polymorphisms of HNF4A and FOXO1 genes and Chinese Han patients with type 2 diabetes.

Tianjie Li1, Xiaopan Wu, Xilin Zhu, Jingyun Li, Liping Pan, Pengtao Li, Zhenhui Xin, Ying Liu.   

Abstract

The hepatocyte nuclear factor 4-alpha (HNF4A) and human forkhead box O1 (FOXO1) genes have been discovered to be associated with type 2 diabetes (T2D) in different populations. This study aimed to evaluate the association between HNF4A and FOXO1 genetic polymorphisms and type 2 diabetes in the Chinese Han population. Five hundred and seventy-seven patients with type 2 diabetes and 462 normal controls were enrolled in this study. Six single-nucleotide polymorphisms (SNPs) in HNF4A and seven in FOXO1 were selected and genotyped with polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) or TaqMan(®) technology. Single-locus analyses indicated that the C allele of rs11574736 from HNF4A had a lower frequency in the case group compared with the control group (P = 0.005, OR = 0.74, 95% CI = 0.59-0.92). The genotype distributions of rs11574736 also differed between the two groups (P = 0.02). However, none of the FOXO1 SNPs showed any association with type 2 diabetes in the Chinese Han population. Further analysis suggested the two genes interact with each other (rs3908773/rs717247/rs6031587/rs11574736: P < 0.0001, testing accuracy = 0.55, CV consistency = 6/10). In conclusion, this study shows an association between the HNF4A gene and type 2 diabetes in the Chinese Han population. Moreover, the authors confirmed the results of previous studies for the interaction between HNF4A and FOXO1 in the pathogenesis of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21442235     DOI: 10.1007/s11010-011-0794-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  Prevalence of diabetes among men and women in China.

Authors:  Wenying Yang; Juming Lu; Jianping Weng; Weiping Jia; Linong Ji; Jianzhong Xiao; Zhongyan Shan; Jie Liu; Haoming Tian; Qiuhe Ji; Dalong Zhu; Jiapu Ge; Lixiang Lin; Li Chen; Xiaohui Guo; Zhigang Zhao; Qiang Li; Zhiguang Zhou; Guangliang Shan; Jiang He
Journal:  N Engl J Med       Date:  2010-03-25       Impact factor: 91.245

2.  The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth.

Authors:  Tadahiro Kitamura; Jun Nakae; Yukari Kitamura; Yoshiaki Kido; William H Biggs; Christopher V E Wright; Morris F White; Karen C Arden; Domenico Accili
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  A transcription factor regulatory circuit in differentiated pancreatic cells.

Authors:  S F Boj; M Parrizas; M A Maestro; J Ferrer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

4.  A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young.

Authors:  H Thomas; K Jaschkowitz; M Bulman; T M Frayling; S M Mitchell; S Roosen; A Lingott-Frieg; C J Tack; S Ellard; G U Ryffel; A T Hattersley
Journal:  Hum Mol Genet       Date:  2001-09-15       Impact factor: 6.150

5.  Identification of polymorphic antioxidant response elements in the human genome.

Authors:  Xuting Wang; Daniel J Tomso; Brian N Chorley; Hye-Youn Cho; Vivian G Cheung; Steven R Kleeberger; Douglas A Bell
Journal:  Hum Mol Genet       Date:  2007-04-04       Impact factor: 6.150

6.  Variants in hepatocyte nuclear factor 4alpha gene promoter region and type 2 diabetes risk in Chinese.

Authors:  Zhuo Chen; Di Zhang; Yun Liu; Daizhan Zhou; Teng Zhao; Yifeng Yang; Lin He; He Xu
Journal:  Exp Biol Med (Maywood)       Date:  2010-07

7.  Association of common genetic variation in the FOXO1 gene with beta-cell dysfunction, impaired glucose tolerance, and type 2 diabetes.

Authors:  Karsten Müssig; Harald Staiger; Fausto Machicao; Alena Stancáková; Johanna Kuusisto; Markku Laakso; Claus Thamer; Jürgen Machann; Fritz Schick; Claus D Claussen; Norbert Stefan; Andreas Fritsche; Hans-Ulrich Häring
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

8.  Analysis of FOXO1A as a candidate gene for type 2 diabetes.

Authors:  Mohammad A Karim; Rebekah L Craig; Xiaoqin Wang; Terri C Hale; Steven C Elbein
Journal:  Mol Genet Metab       Date:  2006-02-23       Impact factor: 4.797

9.  A SNP haplotype of the forkhead transcription factor FOXO1A gene may have a protective effect against type 2 diabetes in German Caucasians.

Authors:  Y Böttcher; A Tönjes; B Enigk; G H Scholz; M Blüher; M Stumvoll; P Kovacs
Journal:  Diabetes Metab       Date:  2007-06-06       Impact factor: 6.041

10.  Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1.

Authors:  Jun Nakae; William H Biggs; Tadahiro Kitamura; Webster K Cavenee; Christopher V E Wright; Karen C Arden; Domenico Accili
Journal:  Nat Genet       Date:  2002-09-03       Impact factor: 38.330

View more
  4 in total

1.  Estrogen receptor alpha gene polymorphisms are associated with type 2 diabetes and fasting glucose in male subjects.

Authors:  Reza Meshkani; Hamzeh Saberi; Narges MohammadTaghvaei; Mohammad Amin Tabatabaiefar
Journal:  Mol Cell Biochem       Date:  2011-08-12       Impact factor: 3.396

2.  Association of FOXO1 Rs17592236 Polymorphism and Tumor Size in Papillary Thyroid Carcinoma.

Authors:  Shaghayegh Saljooghi; Zahra Heidari; Mohsen Saravani; Mahnaz Rezaei; Saeedeh Salimi
Journal:  Rep Biochem Mol Biol       Date:  2022-07

3.  Predisposition to Behçet's disease and VKH syndrome by genetic variants of miR-182.

Authors:  Hongsong Yu; Yunjia Liu; Lin Bai; Aize Kijlstra; Peizeng Yang
Journal:  J Mol Med (Berl)       Date:  2014-05-08       Impact factor: 4.599

4.  The FOXO1 Gene-Obesity Interaction Increases the Risk of Type 2 Diabetes Mellitus in a Chinese Han Population.

Authors:  Lilin Gong; Rong Li; Wei Ren; Zengchan Wang; Zhihong Wang; Maosheng Yang; Suhua Zhang
Journal:  J Korean Med Sci       Date:  2017-02       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.